Results 151 to 160 of about 288,801 (266)

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Towards resilient and agile health systems: lessons from abrupt donor withdrawal in Jordan. [PDF]

BMJ Open Qual
Jaouni S, Lachman P, Hassan S.
europepmc   +1 more source

Remarkable Recovery After Delayed High‐Dose Methylprednisolone in a Rare Case of Penetrating Spinal Cord Injury

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Traumatic spinal cord injury (TSCI) caused by sharp‐force penetration is exceptionally rare, and the use of high‐dose methylprednisolone (MP) remains highly controversial, especially beyond the conventional 8‐h treatment window. This case report describes a 30‐year‐old male with acute incomplete TSCI following a knife stab wound to the right ...
Honghong Wang, Shuang Liu, Jiale Wang, Kaiyang Xue, Shenwei Li, Zhongheng Du   +5 more
wiley   +1 more source

Addressing low-value care (LVC) in Asia: a narrative review of Choosing Wisely and other initiatives across Asia. [PDF]

BMJ Open Qual
Yeo JX, Tokuda Y, Sasaki S, Pan J, Kamaruzaman H, Ranganathan P, Lu L, Mohamad Yusof A, Izaham A, Pramesh CS, Abdullah HR.   +10 more
europepmc   +1 more source

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez, Monica Ferrer Socorro, Kathryn Yang, Nicole Battaglia, Zainab Zaman, Mariko Bennett, Adeline Vanderver, Pui Y. Lee, Lauren A. Henderson, Milena M. Andzelm, Darius Ebrahimi‐Fakhari   +10 more
wiley   +1 more source

Australian Rural Surgical Workforce: A Policy Analysis. [PDF]

Aust J Rural Health
Carmichael GJ, Tranquille T, Di Tano V, Al-Sharea A, Kovoor JG, Jacob MO.   +5 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

National capacity-building initiatives for childhood hematologic malignancies in Myanmar

Blood Advances, 2017
Tint Myo Hnin, Aye Aye Khaing, Yi Yi Kyaw, Catherine G. Lam, Carlos Rodriguez- Galindo, Robert Carr, Liz Burns, Htaik Tint Tun, Pe Thet Khin   +8 more
doaj   +1 more source

Dementia Care in an Aging World: Achievements, Challenges, and Future Directions. [PDF]

Geriatr Gerontol Int
Takechi H.
europepmc   +1 more source